C4 Therapeutics' GAAP loss for 9M 2021 was $68.234 million, up 53.2% from $44.54 million in the prior year. Revenue increased 3.1% to $25.707 million from $24.933 million a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept